Core Laboratories (NYSE:CLB - Get Free Report) announced its quarterly earnings data on Wednesday. The oil and gas company reported $0.23 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.23, Zacks reports. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. Core Laboratories updated its Q1 2025 guidance to 0.120-0.160 EPS.
Core Laboratories Stock Down 0.1 %
Shares of Core Laboratories stock traded down $0.01 on Wednesday, hitting $18.52. 364,199 shares of the company traded hands, compared to its average volume of 271,050. Core Laboratories has a 12-month low of $13.82 and a 12-month high of $25.13. The company has a quick ratio of 1.79, a current ratio of 2.48 and a debt-to-equity ratio of 0.55. The company has a market cap of $869.42 million, a PE ratio of 28.49, a PEG ratio of 1.14 and a beta of 2.39. The company has a 50-day moving average price of $19.04 and a 200 day moving average price of $19.50.
Analyst Upgrades and Downgrades
Several research analysts have commented on the stock. StockNews.com upgraded shares of Core Laboratories from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Citigroup decreased their price objective on Core Laboratories from $15.00 to $14.00 and set a "sell" rating for the company in a report on Thursday, October 31st. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $17.00.
View Our Latest Stock Report on Core Laboratories
Core Laboratories Company Profile
(
Get Free Report)
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Core Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Laboratories wasn't on the list.
While Core Laboratories currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.